
Long Regulatory Saga for Intercept Pharma Liver Drug Ends a Decade After Speedy FDA Approval
Intercept Pharmaceuticals is voluntarily withdrawing from the market Ocaliva, a drug for the rare liver…
Intercept Pharmaceuticals is voluntarily withdrawing from the market Ocaliva, a drug for the rare liver disease primary biliary cholangitis. While Ocaliva became an important new treatment option when it won accelerated FDA approval in 2016, PBC patients now have new FDA-approved medicines from Ipsen and Gilead Sciences that don’t pose the same safety risks. The…
BOWMAN, N.D. — Independent rural hospitals are increasingly forming collaborative groups to share resources and combine bargaining power with the goal of saving money and improving patient care. The networks, which have cropped up in several states in recent years, offer small-town hospitals an alternative to selling to large hospital systems and forfeiting local autonomy. …
The coming changes in Medicaid will place health plans squarely between a rock and a hard place. Here’s how plans are bracing for change. The post Health Plan Leaders Reveal Underreported Medicaid Challenges, Anticipated Risks, and Solutions appeared first on MedCity News.
Instead of creating new opportunities, traditional EMRs are constraining AI’s potential in healthcare. The post Why Traditional EMRs Are Holding Healthcare Back appeared first on MedCity News.
This policy watch examines state-by-state school vaccine requirements and exemptions, including recent policy changes to them and the extent to which they may affect vaccination rates.
This policy watch examines state-by-state school vaccine requirements and exemptions, including recent policy changes to them and the extent to which they may affect vaccination rates.
The conference is scheduled for Thursday, September 18 at Pegasus Park in Dallas in partnership with Health Wildcatters. Register today! The post Your Guide to the Hottest Topics on AI in Healthcare in Dallas Next Week at INVEST Digital Health appeared first on MedCity News.
ST. LOUIS — Lying on top of an operating room table with his chest exposed, Larry Black Jr. was moments away from having his organs harvested when a doctor ran breathlessly into the room. “Get him off the table,” the doctor recalled telling the surgical team at SSM Health Saint Louis University Hospital as the…
FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency’s decisions from public scrutiny. The agency “would like to get away” from assembling panels of experts to examine and vote on individual drugs, because “I don’t…
New moms all over social media are breaking down their incredibly expensive hospital bills after giving birth. So why is giving birth so pricey in the U.S.? And given the Trump administration’s anti-abortion, pro-natalist policies, is anything on the table to make having a child more affordable? KFF Health News video producer Hannah Norman spoke…